enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. A Guide for Living With COPD - AOL

   www.aol.com/guide-living-copd-210000074.html

   COPD is a risk factor for coronary artery disease (CAD)—a type of heart disease caused by buildup of plaque in the arteries, says Dr. Attaway. Research suggests that CAD is a leading cause of ...

3. Fluticasone furoate/umeclidinium bromide/vilanterol - Wikipedia

   en.wikipedia.org/wiki/Fluticasone_furoate/...

   Fluticasone furoate/umeclidinium bromide/vilanterol, sold under the brand name Trelegy Ellipta among others, is a fixed-dose combination inhaled medication that is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). [6] [7] The medications work in different ways: fluticasone furoate is an inhaled corticosteroid ...

4. FDA approves new COPD drug developed by firm in Raleigh ... - AOL

   www.aol.com/news/fda-approves-copd-drug...

   A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade.

5. Fluticasone propionate - Wikipedia

   en.wikipedia.org/wiki/Fluticasone_propionate

   Fluticasone propionate, sold under the brand names Flovent and Flonase among others, is a glucocorticoid steroid medication. [8] When inhaled it is used for the long term management of asthma and COPD. [8]

6. List of largest selling pharmaceutical products - Wikipedia

   en.wikipedia.org/wiki/List_of_largest_selling...

   Best selling pharmaceuticals of 2017/18. The top 16 best selling pharmaceuticals of 2017/18. [2] Rank Drug Main indication Trade name 2018 sales (million USD)

7. Verona prices lung disease therapy above expectations at ...

   www.aol.com/news/verona-pharmas-inhaled-copd...

   The U.S. health regulator's assent on Wednesday for the therapy, branded as Ohtuvayre, gives patients with chronic obstructive pulmonary disease (COPD) a new inhalable, non-steroid treatment.